Investing in Tonix Pharmaceuticals Holding Corp. (TNXP): What You Must Know


Tonix Pharmaceuticals Holding Corp.’s filing revealed that its Chief Executive Officer LEDERMAN SETH acquired Company’s shares for reported $34200.0 on Jun 29. In the deal valued at $1.71 per share,20,000 shares were bought. As a result of this transaction, LEDERMAN SETH now holds 24,235 shares worth roughly $ 10905.75.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Then, LEDERMAN SETH bought 100,000 shares, generating $24,500 in total proceeds. Upon buying the shares at $0.24, the Chief Executive Officer now owns 112,177 shares.

Noble Capital Markets initiated its Tonix Pharmaceuticals Holding Corp. [TNXP] rating to an Outperform in a research note published on Friday. A number of analysts have revised their coverage, including ROTH Capital’s analysts, who increased its forecast for the stock in mid April from “a Neutral” to “a Buy”. ROTH Capital also remained covering TNXP and has increased its forecast on August 18, 2017 with a “Buy” recommendation from previously “Neutral” rating. ROTH Capital revised its rating on September 07, 2016. It rated TNXP as “a Neutral” which previously was an “a Buy”.

Price Performance Review of TNXP

On Friday, Tonix Pharmaceuticals Holding Corp. [NASDAQ:TNXP] saw its stock fall -1.08% to $0.45. On the same session, the stock had its day’s lowest price of $0.4444, but rose to a high of $0.46. Over the last five days, the stock has lost -4.25%. Tonix Pharmaceuticals Holding Corp. shares have fallen nearly -96.07% since the year began. Nevertheless, the stocks have fallen -97.48% over the past one year. While a 52-week high of $19.43 was reached on 01/04/22, a 52-week low of $0.44 was recorded on 11/03/22. SMA at 50 days reached $0.6538, while 200 days put it at $3.3104. A total of 0.66 million shares were traded, compared to the trading of 1.19 million shares in the previous session.

Levels Of Support And Resistance For TNXP Stock

The 24-hour chart illustrates a support level at 0.4430, which if violated will result in even more drops to 0.4359. On the upside, there is a resistance level at 0.4586. A further resistance level may holdings at 0.4671. The Relative Strength Index (RSI) on the 14-day chart is 28.39, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0257, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.37%. Stochastics %K at 13.30% indicates the stock is a buying.

How much short interest is there in Tonix Pharmaceuticals Holding Corp.?

A steep rise in short interest was recorded in Tonix Pharmaceuticals Holding Corp. stocks on Jul 14, 2022, dropping by -0.79 million shares to a total of 0.77 million shares. Yahoo Finance data shows the prior-month short interest on Jun 14, 2022 was 1.56 million shares. There was a decline of -101.33%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 2.45% of the overall stock float, the days-to-cover ratio (short ratio) fell to 0.28.

Tonix Pharmaceuticals Holding Corp. [TNXP] – Who Are The Largest Shareholders?

In filings from Morgan Stanley Smith Barney LLC, it is revealed that the company now owns 833,321 shares, or roughly 1.86% of the outstanding TNXP shares. In other words, the investor’s shares have risen by 831,983 from its previous 13-F filing of 1338.0. Additionally, The Vanguard Group, Inc. increased 29.86% of its stake after which the total value it holdings stand at $388,953, while Renaissance Technologies LLC added 7.18% of its stake to hold $0.34 million in the firm. At present, BlackRock Fund Advisors is holding 319,304 shares valued at $0.17 million. Azimut Capital Management SGR SpA owned 304,687 shares of the company at the time of its most recent 13F filing, worth $0.16 million.

According to FactSet, Tonix Pharmaceuticals Holding Corp.’s share price will average $6.50 in the next year, based on opinions of analysts polled by the firm. This is up nearly 1313.04 percent from its previous closing price of $0.46. Analysts expect Tonix Pharmaceuticals Holding Corp. stock to reach the higher price of $6.50, while the lowest price estimate is $6.50. However, 1 analyst have rated TNXP stock as a Buy in their predictions for 2022. The most recent change occurred on February 17, 2016 when Oppenheimer resumed its ‘”an Outperform”‘ rating for the stock and retained the price target to $10.


Please enter your comment!
Please enter your name here